Clinical trial
A Randomized, Evaluator-blinded, Parallel Group, Comparator-controlled, Multicenter Study to Evaluate the Safety and Effectiveness of GP0116 for Correction of Moderate to Severe Dynamic Facial Wrinkles and Folds, Such as Nasolabial Folds.
NCT05987163 is registered in ClinicalTrials.gov with Galderma R&D as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Evaluator-blinded, Parallel Group, Comparator-controlled, Multicenter Study to Evaluate the Safety and Effectiveness of GP0116 for Correction of Moderate to Severe Dynamic Facial Wrinkles and Folds, Such as Nasolabial Folds.
- Lead sponsor
- Galderma R&D
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- April 12, 2023
- Completion date
- March 31, 2026
- Enrollment
- 186 (estimated)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.